Faculty

Back to Index
Anne Louise Peters, MD
Professor of Clinical Medicine
Medicine
Westside Center for Diabetes Off Campus Beverly Hills
+1 310 657 3030

Overview

Anne Peters, M.D., is Professor of Medicine at the Keck School of Medicine of USC and Director of the USC Clinical Diabetes Programs. Dr. Peters earned her medical degree from the Pritzker School of Medicine at the University of Chicago and performed an internal medicine residency at Stanford University and an endocrinology fellowship at Cedars-Sinai Medical Center. She previously directed the clinical diabetes programs at Cedars-Sinai and UCLA. Her research has focused on testing new approaches for diagnosing and treating diabetes and developing systems of care to improve outcomes in diabetic populations.

She has published over 200 articles, reviews, and abstracts and three books on diabetes. She has been an investigator on over 40 research studies and has spoken at over 400 programs throughout the US as well as internationally. She has served on many committees for the ADA and other organizations. Currently she is the chair of the Endocrine Society Committee on Diabetes Devices and is on the EASD/ADA Technology Safety Committee. Additionally she is a member of the JDRF Panel on Management of Exercise in Type 1 Diabetes. She is a member of the ABIM Endocrinology Subspecialty Board. She consults for many entities, including the FDA, Optum Rx and CVS/Caremark to help guide the development and use of treatments for diabetes.

Awards

National Minority Quality Forum: Bernardo Alberto Houssay Award, 2010

American Diabetes Association: Outstanding Physician Clinician Award, 2008

Safety Net Award

Diabetes Management Clinic: Honorable Mention, 2004

Best Doctors in America

Cedars-Sinai Medical Center: Morris Press Humanism Award, 1991

American College of Physicians: Fellow, 1991

American Medical Women's Association: Citation for Scholastic Achievement, 1983

National Institutes of Health Summer Research Award

American Association for the Advancement of Science: Research Award, 1974

Publications

. T1-REDEEM: A Randomized Controlled Trial to Reduce Diabetes Distress Among Adults With Type 1 Diabetes Diabetes Care. 2018 Jul 05. View in: PubMed

. Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study Diabetes Care. 2018 Jun 24. View in: PubMed

. HbA1c and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study Diabetes Care. 2018 Jun 24. View in: PubMed

. A Physician's Place in the #MeToo Movement Ann Intern Med. 2018 May 01; 168(9):676-677. View in: PubMed

. Impact of Intensive Lifestyle Intervention on Disability-Free Life Expectancy: The Look AHEAD Study Diabetes Care. 2018 May; 41(5):1040-1048. View in: PubMed

. Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study Diabetes Ther. 2018 Apr; 9(2):583-612. View in: PubMed

. Occupational Therapy Intervention Improves Glycemic Control and Quality of Life Among Young Adults With Diabetes: the Resilient, Empowered, Active Living with Diabetes (REAL Diabetes) Randomized Controlled Trial Diabetes Care. 2018 Apr; 41(4):696-704. View in: PubMed

. Author Correction: Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study Diabetes Ther. 2018 Apr; 9(2):613-621. View in: PubMed

. The relationship between adherence and total spending among Medicare beneficiaries with type 2 diabetes Am J Manag Care. 2017 Apr; 23(4):248-252. View in: PubMed

. Clinical and Psychosocial Outcomes of a Structured Transition Program Among Young Adults With Type 1 Diabetes J Adolesc Health. 2017 Feb; 60(2):212-218. View in: PubMed

. Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations: A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group Diabetes Care. 2017 12; 40(12):1614-1621. View in: PubMed

. REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes Diabetes Care. 2017 04; 40(4):538-545. View in: PubMed

. Resilient, Empowered, Active Living with Diabetes (REAL Diabetes) study: Methodology and baseline characteristics of a randomized controlled trial evaluating an occupation-based diabetes management intervention for young adults Contemp Clin Trials. 2017 03; 54:8-17. View in: PubMed

. Health Care Transition Preparation and Experiences in a US. National Sample of Young Adults With Type 1 Diabetes. Diabetes Care. 2017 03; 40(3):317-324. View in: PubMed

. The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People With Type 1 Diabetes Diabetes Care. 2017 02; 40(2):171-180. View in: PubMed

. Rethinking Rates of Undiagnosed Diabetes: The Value of a Confirmatory Test Ann Intern Med. 2017 12 05; 167(11):822-823. View in: PubMed

. Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline J Clin Endocrinol Metab. 2016 Nov; 101(11):3922-3937. View in: PubMed

. Four-Year Physical Activity Levels among Intervention Participants with Type 2 Diabetes Med Sci Sports Exerc. 2016 12; 48(12):2437-2445. View in: PubMed

. Hypoglycemia in Older Adults with Type 1 Diabetes Diabetes Technol Ther. 2016 12; 18(12):765-771. View in: PubMed

. The Impact of Real-Time Continuous Glucose Monitoring in Patients 65 Years and Older J Diabetes Sci Technol. 2016 07; 10(4):892-7. View in: PubMed

. Risk Factors Associated With Severe Hypoglycemia in Older Adults With Type 1 Diabetes Diabetes Care. 2016 04; 39(4):603-10. View in: PubMed

. Diabetic Ketoacidosis With Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, in Patients With Type 1 Diabetes Diabetes Care. 2016 04; 39(4):532-8. View in: PubMed

. Clinical and Economic Impact of a Digital, Remotely-Delivered Intensive Behavioral Counseling Program on Medicare Beneficiaries at Risk for Diabetes and Cardiovascular Disease PLoS One. 2016; 11(10):e0163627. View in: PubMed

. Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition Diabetes Care. 2015 Sep; 38(9):1687-93. View in: PubMed

. Let's Empower and Prepare (LEAP): Evaluation of a Structured Transition Program for Young Adults With Type 1 Diabetes Diabetes Care. 2015 Aug; 38(8):1412-9. View in: PubMed

. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needsA joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. Diabetologia. 2015 May; 58(5):862-70. View in: PubMed

. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group Diabetes Care. 2015 Apr; 38(4):716-22. View in: PubMed

. Response to comment on Wong et alReal-time continuous glucose monitoring among participants in the T1D exchange clinic registry. Diabetes Care 2014;37:2702-2709. Diabetes Care. 2015 Apr; 38(4):e61. View in: PubMed

. Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approachUpdate to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2015 Mar; 58(3):429-42. View in: PubMed

. Prevalence of detectable C-Peptide according to age at diagnosis and duration of type 1 diabetes Diabetes Care. 2015 Mar; 38(3):476-81. View in: PubMed

. Primary care medical home experience and health-related quality of life among adult medicaid patients with type 2 diabetes J Gen Intern Med. 2015 Feb; 30(2):161-8. View in: PubMed

. Patient perspectives on peer mentoring: type 1 diabetes management in adolescents and young adults Diabetes Educ. 2015 02; 41(1):59-68. View in: PubMed

. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care. 2015 Jan; 38(1):140-9. View in: PubMed

. The Look AHEAD Trial: bone loss at 4-year follow-up in type 2 diabetes Diabetes Care. 2014 Oct; 37(10):2822-9. View in: PubMed

. Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry Diabetes Care. 2014 Oct; 37(10):2702-9. View in: PubMed

. Do experiences consistent with a medical-home model improve diabetes care measures reported by adult Medicaid patients? Diabetes Care. 2014 Sep; 37(9):2565-71. View in: PubMed

. "We are all gonna get diabetic these days": the impact of a living legacy of type 2 diabetes on Hispanic young adults' diabetes care Diabetes Educ. 2014 Sep-Oct; 40(5):648-58. View in: PubMed

. Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetes Diabetes Care. 2014 Sep; 37(9):2548-56. View in: PubMed

. GLP-1 provoked severe hypoglycemia in an individual with type 2 diabetes and a benign insulinoma Diabetes Care. 2014 Aug; 37(8):e177-8. View in: PubMed

. Type 1 diabetes through the life span: a position statement of the American Diabetes Association Diabetes Care. 2014 Jul; 37(7):2034-54. View in: PubMed

. Healthcare costs and adherence associated with human regular U-500 versus high-dose U-100 insulin in patients with diabetes Endocr Pract. 2014 Jul; 20(7):663-70. View in: PubMed

. Depression in adults in the T1D Exchange Clinic Registry Diabetes Care. 2014 Jun; 37(6):1563-72. View in: PubMed

. Trial to examine text message-based mHealth in emergency department patients with diabetes (TExT-MED): a randomized controlled trialAnn Emerg Med. 2014 Jun; 63(6):745-54. e6. View in: PubMed

. Durability of glycemic control with insulin lispro mix 75/25 versus insulin glargine for older patients with type 2 diabetes Aging Clin Exp Res. 2014 Apr; 26(2):115-21. View in: PubMed

. Translating the Diabetes Prevention Program into an Online Social Network: Validation against CDC Standards Diabetes Educ. 2014 07; 40(4):435-443. View in: PubMed

. Continuous glucose monitoring pilot in low-income type 1 diabetes patients Diabetes Technol Ther. 2013 Oct; 15(10):855-8. View in: PubMed

. Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry J Clin Endocrinol Metab. 2013 Aug; 98(8):3411-9. View in: PubMed

. Intensive weight loss intervention in older individuals: results from the Action for Health in Diabetes Type 2 diabetes mellitus trial J Am Geriatr Soc. 2013 Jun; 61(6):912-22. View in: PubMed

. Cost, healthcare resource utilization, and adherence of individuals with diabetes using U-500 or U-100 insulin: a retrospective database analysis J Med Econ. 2013; 16(4):529-38. View in: PubMed

. Exenatide therapy and the risk of pancreatitis and pancreatic cancer in a privately insured population Diabetes Technol Ther. 2012 Oct; 14(10):904-11. View in: PubMed

. Challenges in applying diabetes technology to clinical care Diabetes Technol Ther. 2012 Oct; 14(10):849-50. View in: PubMed

. Expenditures for medicaid patients treated with exenatide compared with other diabetes management regimens Am J Manag Care. 2012 Sep; 18(8 Suppl):s191-202. View in: PubMed

. A mobile health intervention for inner city patients with poorly controlled diabetes: proof-of-concept of the TExT-MED program Diabetes Technol Ther. 2012 Jun; 14(6):492-6. View in: PubMed

. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetes Care. 2012 Jun; 35(6):1364-79. View in: PubMed

. Trends in diabetes-related visits to US EDs from 1997 to 2007 Am J Emerg Med. 2012 Jun; 30(5):754-8. View in: PubMed

. Effect of 1 year of an intentional weight loss intervention on bone mineral density in type 2 diabetes: results from the Look AHEAD randomized trial J Bone Miner Res. 2012 Mar; 27(3):619-27. View in: PubMed

. Incretin-based therapies: review of current clinical trial data Am J Med. 2010 Mar; 123(3 Suppl):S28-37. View in: PubMed

. Patient and treatment perspectives: Revisiting the link between type 2 diabetes, weight gain, and cardiovascular risk Cleve Clin J Med. 2009 Dec; 76 Suppl 5:S20-7. View in: PubMed

. Clinical practice in type 2 diabetes: After metformin and lifestyle, then what? J Fam Pract. 2009 Nov; 58(11 Suppl Clinical):S7-14. View in: PubMed

. A piece of my mindClinic of tears. JAMA. 2009 Jun 10; 301(22):2309. View in: PubMed

. Food and park environments: neighborhood-level risks for childhood obesity in east Los Angeles J Adolesc Health. 2007 Apr; 40(4):325-33. View in: PubMed

. Case study 2: new insights: clinical pearls for using incretin mimetics in type 2 diabetes Diabetes Educ. 2007 Jan-Feb; 33 Suppl 1:14S-19S. View in: PubMed

. Identification of appropriate patients for cardiometabolic risk management Rev Cardiovasc Med. 2007; 8 Suppl 4:S9-16. View in: PubMed

. Short and longer term outcomes of a diabetes disease management program in underserved Latino patients Curr Med Res Opin. 2005 Dec; 21(12):1935-41. View in: PubMed

Powered bySC CTSI